The transferability of international economic health-economic results to national study questionsWolfgang Greiner, J.‐Matthias Graf v. d. Schulenburg, Oliver Schöffski|The European Journal of Health Economics|2000Cited by 29
Using Disease Management and Market Reforms to Address the Adverse Economic Effects of Drug Budgets and Price and Reimbursement Regulations in GermanyTim Schwermann, J.‐Matthias Graf v. d. Schulenburg, Wolfgang Greiner|Value in Health|2003Cited by 21
Methods for determining cost-benefit ratios for pharmaceuticals in GermanyJ.‐Matthias Graf v. d. Schulenburg, Wolfgang Greiner, Christoph Vauth et al.|The European Journal of Health Economics|2007Cited by 17